
Ron Manuel🇨🇦🇺🇸
1.5K posts

Ron Manuel🇨🇦🇺🇸
@RonManuel2
Canadian/American, retired law firm COO. CPA, MBA










1,000 kcal of low-intensity exercise every day keeps the Doctor away. 2,000 kcal of low-intensity exercise every day keeps the competition at bay.









One of the most meaningful evolutions in the 2026 ACC/AHA dyslipidemia guideline is the continued elevation of CAC as a central tool in preventive decision-making. We have come a long way. 1. In the 2013 guidelines, CAC was effectively sidelined. 2. By 2019, it re-emerged as a decision aid. 3. In 2026, it is now clearly embedded in the framework of risk assessment, treatment initiation, and treatment intensity. Two messages stand out. 1. First, CAC has become the preferred decision aid when treatment decisions are uncertain. This is not an uncommon situation. In real-world practice, uncertainty is the rule rather than the exception, especially in borderline or intermediate-risk individuals. #PowerOfZero provides a clear distinction who is and not at risk that for the decision whether lipid-lowering therapy should be initiated. 2. Second, the guideline goes beyond initiation. CAC is increasingly used to guide the intensity of therapy. Increasing plaque burden corresponds to progressively more aggressive LDL targets and therapeutic strategies. For example, individuals with CAC ≥300–1000 are recommended to pursue LDL reduction strategies approaching secondary prevention intensity, reflecting event rates comparable to treated ASCVD populations. This is a MAJOR shift. CAC is no longer simply a tie-breaker for statin decisions. It is evolving into a disease-guided framework for preventive intensity. From a practical standpoint, this matters.Risk equations estimate probability. CAC visualizes disease. 1. When uncertainty exists, seeing the burden of atherosclerosis often changes the conversation for both clinician and patient. 2. It also aligns therapy more closely with biology (GREATER DISEASE, MORE INTENSE THE TREATMENT) rather than risk-factor projections alone. IN 2026. CAC has moved from the margins of guidelines to the center of preventive cardiology. For clinicians, that represents one of the most practical advances in translating risk assessment into actionable care. Congrats @rblument1 @RonBlankstein @DrMichaelShapir & rest of the guideline authors @AJPCardio @ASPCardio @MichaelJBlaha @Sadeer_AlKindi @HMethodistCV



FINALLY someone is saying it out loud Casey Means explains the only reason everyone has to go and see a “specialist” for every single different part of the body now instead of just one doctor is because the medial industrial complex makes more money It’s by design. For profit.

@Alan_Couzens What are scores you’d like to see for a male aged 50?




Taking ~2 grams/day of fish oil is enough to move most people from a low omega-3 index (~4%) to the optimal range (~8%), with major benefits: • ~90% lower risk of sudden cardiac death • ~5-year increase in life expectancy (at higher omega-3 index levels) • Lower risk of dementia and other neurodegenerative disease • ~30% reduced heart attack risk (VITAL study) • ~25% fewer adverse cardiac events (REDUCE-IT trial) Concerns about “oxidized fish oil” are often overstated Quality definitely matters, but the bigger risk is not getting enough omega-3s at all


















